Functional study of elafin cleaved by Pseudomonas aeruginosa metalloproteinases.
Butler, Marcus W
Greene, Catherine M
Levine, Rodney L
O'Neill, Shane J
Taggart, Clifford C
McElvaney, Noel G
AffiliationDepartment of Medicine, Pulmonary Research Division, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Ireland.
Chromatography, High Pressure Liquid
Electrophoresis, Polyacrylamide Gel
MetadataShow full item record
CitationFunctional study of elafin cleaved by Pseudomonas aeruginosa metalloproteinases. 2010, 391 (6):705-16 Biol. Chem.
AbstractElafin is a 6-kDa innate immune protein present at several epithelial surfaces including the pulmonary epithelium. It is a canonical protease inhibitor of two neutrophil serine proteases [neutrophil elastase (NE) and proteinase 3] with the capacity to covalently bind extracellular matrix proteins by transglutamination. In addition to these properties, elafin also possesses antimicrobial and immunomodulatory activities. The aim of the present study was to investigate the effect of Pseudomonas aeruginosa proteases on elafin function. We found that P. aeruginosa PAO1-conditioned medium and two purified Pseudomonas metalloproteases, pseudolysin (elastase) and aeruginolysin (alkaline protease), are able to cleave recombinant elafin. Pseudolysin was shown to inactivate the anti-NE activity of elafin by cleaving its protease-binding loop. Interestingly, antibacterial properties of elafin against PAO1 were found to be unaffected after pseudolysin treatment. In contrast to pseudolysin, aeruginolysin failed to inactivate the inhibitory properties of elafin against NE. Aeruginolysin cleaves elafin at the amino-terminal Lys6-Gly7 peptide bond, resulting in a decreased ability to covalently bind purified fibronectin following transglutaminase activity. In conclusion, this study provides evidence that elafin is susceptible to proteolytic cleavage at alternative sites by P. aeruginosa metalloproteinases, which can affect different biological functions of elafin.
- Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.
- Authors: Guyot N, Butler MW, McNally P, Weldon S, Greene CM, Levine RL, O'Neill SJ, Taggart CC, McElvaney NG
- Issue date: 2008 Nov 21
- Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate.
- Authors: Baranger K, Zani ML, Labas V, Dallet-Choisy S, Moreau T
- Issue date: 2011
- Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase.
- Authors: Guyot N, Zani ML, Maurel MC, Dallet-Choisy S, Moreau T
- Issue date: 2005 Nov 29
- Human pre-elafin inhibits a Pseudomonas aeruginosa-secreted peptidase and prevents its proliferation in complex media.
- Authors: Bellemare A, Vernoux N, Morisset D, Bourbonnais Y
- Issue date: 2008 Feb
- Structural and antimicrobial properties of human pre-elafin/trappin-2 and derived peptides against Pseudomonas aeruginosa.
- Authors: Bellemare A, Vernoux N, Morin S, Gagné SM, Bourbonnais Y
- Issue date: 2010 Oct 8